Ophthalmic composition for glaucoma treatment

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 11382887
APP PUB NO 20200129468A1
SERIAL NO

16624560

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

An eye drop composition for treating glaucoma is disclosed. The eye drop composition includes a prostaglandin analogue, a thickening agent, and a solubilizing agent, wherein the thickening agent is carboxymethylcellulose or a salt thereof, and the solubilizing agent is tyloxapol.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
YS LIFE SCIENCE CO LTD207 SUJEONG-RO JANGAN-MYEON HWASEONG-SI GYEONGGI-DO 18581 18581

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Baek, Areum Suwon-si, KR 5 0
Chung, Youngsik Yongin-si, KR 1 0
Lee, Kee Young Seoul, KR 13 16
Oh, Chang Young Seongnam-si, KR 6 12
Shin, Hyun Ik Suwon-si, KR 13 1

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Jan 12, 2026
7.5 Year Payment $3600.00 $1800.00 $900.00 Jan 12, 2030
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jan 12, 2034
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00